Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Francisco De La Vega

Premium

Real Time Genomics has tapped Francisco De La Vega to head the firm's commercial operations as VP of genome science. De La Vega spent 13 years at Applied Biosystems, where he was a scientific fellow and VP of next-generation sequencing applications. He also was a visiting professor at the Department of Genetics of the Stanford School of Medicine, where he conducted research in population genetics, and he was a member of the steering committee of the 1000 Genomes Project Consortium.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.